{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:12:00Z","timestamp":1778314320307,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1212\/wnl.51.1.221","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:34:42Z","timestamp":1336916082000},"page":"221-228","source":"Crossref","is-referenced-by-count":87,"title":["A phase I\/II trial of nimodipine for HIV-related neurologic complications"],"prefix":"10.1212","volume":"51","author":[{"given":"B. A.","family":"Navia","sequence":"first","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Dafni","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Simpson","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Tucker","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Singer","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C.","family":"McArthur","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Yiannoutsos","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Zaborski","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. A.","family":"Lipton","sequence":"additional","affiliation":[{"name":"From the Tufts Neurology Program and Department of Psychiatry (Dr. Navia), Tufts University School of Medicine, Boston, MA; Beth Beth Israel Deaconess Medical Center (Drs. Navia and Lipton), Boston; the CNS Research Institute (Dr. Lipton), Brigham and Women's Hospital and Harvard Medical School, Boston; Harvard School of Public Health (Drs. Dafni and Yiannoutsos, and L. Zaborski), Boston; Mt. Sinai School of Medicine (Dr. Simpson), New York, NY; Case Western Reserve University (Dr. Tucker),..."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the AIDS Clinical Trial Group*","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","first-page":"517","volume":"19","year":"1986","unstructured":"Navia BA, Jordan BD, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 1986;19:517-524.","journal-title":"Neurol"},{"key":"e_1_3_1_3_2","first-page":"525","volume":"19","year":"1986","unstructured":"Navia BA, Cho ES, Petito CK, Price RW. The AIDS dementia complex: II. Neuropathology. Ann Neurol 1986;19:525-535.","journal-title":"Neurol"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3277272"},{"key":"e_1_3_1_5_2","first-page":"874","volume":"312","year":"1985","unstructured":"Petito CK, Navia BA, Cho ES, et al. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-879.","journal-title":"Med"},{"key":"e_1_3_1_6_2","first-page":"32","volume":"21","year":"1987","unstructured":"Cornblath DR, McArthur JC, Kennedy PGE, et al. Inflammatory demyelinating peripheral neuropathies associated with human T cell lymphotropic virus type III infection. Ann Neurol 1987;21:32-40.","journal-title":"Neurol"},{"key":"e_1_3_1_7_2","unstructured":"Griffin JW Crawford TO Glass JD et al. Sensory neuropathy in AIDS: II. Immunopathology. Brain 1998 (in press)."},{"key":"e_1_3_1_8_2","first-page":"1573","volume":"319","year":"1988","unstructured":"Schmitt FA, Bigley JW, McKinnis R, et al. Neuropsychological outcome of zidovudine (AZT) treatment of patients with AIDS and AIDS-related complex. N Engl J Med 1988;319:1573-1578.","journal-title":"Med"},{"key":"e_1_3_1_9_2","first-page":"889","volume":"319","year":"1988","unstructured":"Pizzo PA, Eddy J, Falloon J, et al. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 1988;319:889-896.","journal-title":"Med"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6703.819"},{"key":"e_1_3_1_11_2","first-page":"852","volume":"337","year":"1991","unstructured":"Gray F, Geny C, Dournon E, et al. Neuropathological evidence that zidovudine reduces the incidence of HIV infection of brain. Lancet 1991;337:852-853.","journal-title":"Lancet"},{"key":"e_1_3_1_12_2","first-page":"343","volume":"33","year":"1992","unstructured":"Sidtis JJ, Gatsonis C, Price RW, et al. Zidovudine treatment of the AIDS dementia complex: results of a placebo controlled trial. Ann Neurol 1992;33:343-349.","journal-title":"Neurol"},{"key":"e_1_3_1_13_2","first-page":"755","volume":"38","year":"1995","unstructured":"Glass J, Fedor H, Wesselingh SL, McArthur JC. Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia. Ann Neurol 1995;38:755-762.","journal-title":"Neurol"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.83.18.7089"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.3016903"},{"key":"e_1_3_1_16_2","first-page":"490","volume":"21","year":"1987","unstructured":"Pumarola-Sune T, Navia BA, Cordon-Cardi C, Price RW. HIV antigen in the brains of patients with the AIDS dementia complex. Ann Neurol 1987;21:490-496.","journal-title":"Neurol"},{"key":"e_1_3_1_17_2","first-page":"563","volume":"38","year":"1995","unstructured":"Brew B, Rosenblum M, Cronin K, Price RW. AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations. Ann Neurol 1995;38:563-570.","journal-title":"Neurol"},{"key":"e_1_3_1_18_2","first-page":"639","volume":"355","year":"1988","unstructured":"Brennerman DE, Westbrook GL, Fitzgerald SP, et al. Neuronal cell killing by the envelope glycoprotein of HIV and its prevention by vasoactive intestinal peptide. Nature 1988;355:639-642.","journal-title":"Nature"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2148832"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.2326646"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115024"},{"key":"e_1_3_1_22_2","first-page":"2285","volume":"7","year":"1995","unstructured":"Lannuzel A, Liedo P-M, Lamghitnia HO, Vincent JD, Tardieu M. HIV-1 envelope proteins gp120 and gp160 potentiate NMDA-induced(Ca2+) increase, alter (Ca2+)i homeostasis and induce neurotoxicity in human embryonic neurons. Eur J Neurosci 1995;7:2285-2293.","journal-title":"Neurosci"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/367188a0"},{"key":"e_1_3_1_24_2","first-page":"934","volume":"332","year":"1995","unstructured":"Lipton S, Gendelman H. Dementia associated with the acquired immunodeficiency syndrome. N Engl J Med 1995;332:934-940.","journal-title":"Med"},{"key":"e_1_3_1_25_2","first-page":"373","volume":"37","year":"1995","unstructured":"Magnuson DSK, Knudson BE, Geiger JD, Brownstone RM, Nath A. Human immunodeficiency virus type tat activates non-N-methyl-D-aspartate excitatory amino acid receptors and causes neurotoxicity. Ann Neurol 1995;37:373-380.","journal-title":"Neurol"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.274.5294.1917"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.7.4628-4635.1994"},{"key":"e_1_3_1_28_2","first-page":"576","volume":"33","year":"1993","unstructured":"Wesselingh SL, Glass JD, Griffin JW, et al. Intracerebral cytokine expression in the brain during AIDS. Ann Neurol 1993;33:576-589.","journal-title":"Neurol"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.67.5.2844-2852.1993"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-199509020-00004"},{"key":"e_1_3_1_31_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.66.4.2217-2225.1992"},{"key":"e_1_3_1_32_2","first-page":"209","volume":"226","year":"1992","unstructured":"Muller WER, Schroder HC, Ushijima H, Dapper J, Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by memantine. Eur J Pharmacol 1992;226:209-214.","journal-title":"Pharmacol"},{"key":"e_1_3_1_33_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.7.1403"},{"key":"e_1_3_1_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/jn.1996.76.6.3740"},{"key":"e_1_3_1_35_2","first-page":"1079","volume":"158","year":"1988","unstructured":"Price RW, Brew BJ. The AIDS dementia complex. J Infect Dis 1988;158:1079-1083.","journal-title":"Dis"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-198804000-00002"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.2.197"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.2.204"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.39.6.830"},{"key":"e_1_3_1_40_2","first-page":"556","volume":"28","year":"1990","unstructured":"Brew BJ, Bhalla RB, Paul M, et al. Cerebrospinal fluid neopterin in human immunodeficiency virus type 1 infection. Ann Neurol 1990;28:556-560.","journal-title":"Neurol"},{"key":"e_1_3_1_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.42.9.1707"},{"key":"e_1_3_1_42_2","first-page":"437","volume":"326","year":"1992","unstructured":"Hamilton JD, Hartigan PM, Simberkoff MS, et al. A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. N Engl J Med 1992;326:437-443.","journal-title":"Med"},{"key":"e_1_3_1_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.304.6818.13"},{"key":"e_1_3_1_44_2","first-page":"192","volume":"15","year":"1997","unstructured":"Rolinski B, Bogner JR, Sadfri I, et al. Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid of HIV-1 infected patients. J AIDS Hum Retrovirol 1997;15:192-197.","journal-title":"Retrovirol"},{"key":"e_1_3_1_45_2","first-page":"943","volume":"51","year":"1994","unstructured":"Elovaara I, Poutiainen E, Lahdevirta J, et al. Zidovudine reduces intrathecal immunoactivation in patients with early human immunodeficiency virus type 1 infection. Arch Neurol 1994;51:943-950.","journal-title":"Neurol"},{"key":"e_1_3_1_46_2","first-page":"759","volume":"344","year":"1994","unstructured":"Portegeis P, Enting R, De Gans J, et al. AIDS dementia complex and didanosine. Lancet 1994;344:759.","journal-title":"Lancet"},{"key":"e_1_3_1_47_2","doi-asserted-by":"publisher","DOI":"10.3109\/13550289709018299"},{"key":"e_1_3_1_48_2","first-page":"725","volume":"337","year":"1997","unstructured":"Hamer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-733.","journal-title":"Med"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.1.221","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T15:00:53Z","timestamp":1711551653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.1.221"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["10.1212\/WNL.51.1.221"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.1.221","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}